From the Journals

New PsA questionnaire fails to beat existing early screening methods


 

FROM JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY


AbbVie supported this study with an educational grant. The study was supported by the National Institute for Health Research Leeds Biomedical Research Centre. Some of the authors reported potential conflicts of interest.

SOURCE: Coates L et al. J Eur Acad Dermatol Venereol. 2018 Mar 26. doi: 10.1111/jdv.14971.

Next Article:

AbbVie, Samsung Bioepis settle suits with delayed U.S. entry for adalimumab biosimilar

Related Articles

  • Latest News

    Make a PEST of your psoriasis patients

    KAUAI, HAWAII – Every psoriasis patient should complete the Psoriasis Epidemiology Screening Tool (PEST) for psoriatic arthritis annually.